1 evidence check
Last checked: 3/31/2026
The source confirms the $3.05B total funding figure and the Series C round of $2B (EUR1.7B equivalent) led by ASML as of September 2025. However, the claim states '$3.1B' while the source states '$3.05B' — a $50M discrepancy. This is approximately 1.6% higher than the source value, which falls outside typical rounding variance. The claim appears to round up or include additional funding not reflected in the source's documented $3.05B total. The core facts (7 rounds, Series C details, ASML leadership) are confirmed, but the total funding amount is slightly overstated in the claim.
Evidence — 1 source, 1 check
Note: The source confirms the $3.05B total funding figure and the Series C round of $2B (EUR1.7B equivalent) led by ASML as of September 2025. However, the claim states '$3.1B' while the source states '$3.05B' — a $50M discrepancy. This is approximately 1.6% higher than the source value, which falls outside typical rounding variance. The claim appears to round up or include additional funding not reflected in the source's documented $3.05B total. The core facts (7 rounds, Series C details, ASML leadership) are confirmed, but the total funding amount is slightly overstated in the claim.
Debug info
Record type: fact
Record ID: f_PgaGTRoKvg